A PHASE 1 OPEN-LABEL, DOSE-ESCALATION, SAFETY AND TOLERABILITY STUDY OF INCB047986 IN SUBJECTS WITH ADVANCED MALIGNANCIES

Registry ID

INCB 47986-103

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

INCYTE CORPORATION

Last update

2013-11-18

Conditions

• MALIGNANCIES

Related clinical trials

• A RANDOMIZED PHASE I/II STUDY OF ONIVYDE IN COMBINATION WITH TALAZOPARIB OR TEMOZOLOMIDE IN CHILDREN AND YOUNG ADULTS WITH RECURRENT SOLID MALIGNANCIES AND EWING SARCOMA
• PRIMARY THROMBOPROPHYLAXIS IN PATIENTS WITH MALIGNANCY AND CENTRAL VENOUS CATHETERS: A RANDOMIZED CONTROLLED TRIAL (TRIM-LINE)
• A PHASE I, OPEN-LABEL, MULTI-CENTER STUDY OF SAFETY AND DOSE OF FAZ053 AS SINGLE AGENT AND IN COMBINATION WITH PDR001 IN ADULT PATIENTS WITH ADVANCED MALIGNANCIES
• A PHASE IIIB/IV SAFETY TRIAL OF FLAT DOSE NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN PARTICIPANTS WITH ADVANCED MALIGNANCIES

View on source registry